chromium-51 has been researched along with Breast Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kiessling, R; Marmol, P; Pico de Coaña, Y; van der Haar Àvila, I | 1 |
1 other study(ies) available for chromium-51 and Breast Neoplasms
| Article | Year |
|---|---|
Evaluating Antibody-Dependent Cell-Mediated Cytotoxicity by Chromium Release Assay.
Topics: Antibody-Dependent Cell Cytotoxicity; Breast Neoplasms; Cell Line, Tumor; Cell Separation; Chromium Radioisotopes; Cytotoxicity Tests, Immunologic; Female; Flow Cytometry; GPI-Linked Proteins; Humans; Killer Cells, Natural; Receptor, ErbB-2; Receptors, IgG; Trastuzumab | 2019 |